DR LEI HSIEN – HSIEN
Vice President of Medical and Scientific Affairs, Asia Pacific, Medtronic
Dr Hsien-Hsien Lei is Vice President Medical and Scientific Affairs, Asia Pacific (APAC). She oversees APAC medical affairs, clinical research activities, training & education, and value-based healthcare (VBHC), which includes health policy and reimbursement. Hsien is also responsible for communicating Medtronic’s medical and scientific value proposition in a balanced and evidence-based manner to drive the company’s medical, clinical, and scientific leadership in the region.
Hsien’s career has spanned the scientific, clinical, and commercial sides of healthcare with experiences that include bench research, epidemiological and biostatistical data analyses and modeling, pharmacy clerkship, business development, and scientific, medical, and healthcare communications. Prior to Medtronic, Hsien was the general manager of Ogilvy CommonHealth Asia Pacific where she helped clients in pharma, medtech, and public sectors deliver regional integrated healthcare communication programs that encompassed medical education, public relations, advertising and promotion, and digital. In addition, Hsien is an elected member of the American Chamber of Commerce Singapore Board of Governors and Vice Chair of the APACMed Medical and Clinical Affairs Committee.
Hsien has lived and worked in the US, Taiwan, Japan, Vietnam, UK, and is now based in Singapore. She holds a PhD in Epidemiology from The Johns Hopkins University Bloomberg School of Public Health where she was the recipient of a US National Institutes of Health Cardiovascular Disease Epidemiology Training Grant. Her doctoral thesis explored the genetic epidemiology of end-stage renal disease and diabetes. She completed her post-doctoral fellowship at National Taiwan University Hospital in the Department of Endocrinology. Hsien also holds a BA (with honors) in Human Biology from Stanford University.